No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Press Release: Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology
Express News | Gelteq Appoints DR. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology
Gelteq Receives FDA Approval of Its Suitability Petition for New Animal Drug
Gelteq Limited Shares Halted To The Upside; Stock Now Up 49.44%
Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
12 Health Care Stocks Moving In Tuesday's Pre-Market Session